Jluck

BTC • SOL • BNB
Positioning early while others sleep. Stocks | AI | Market Insights 📊

[Jluck @Jluck_2]

Keep waiting!..

[ChooChoo @ChooTheRescue]

We just sent u some cash to buy $Choo on fomo 🐾

[Jluck @Jluck_2]

@ChooTheRescue Bought more with the cash thanks

[ChooChoo @ChooTheRescue]

ART CONTEST 🐾

If you win.

We will pay you in USDC.

If you choose to buy $CHOO and hold for 30 days.

We will double it.

To enter:
Please comment below👇🏼 you’re in.

You’ll have 7 days 🤝

[Jluck @Jluck_2]

@ChooTheRescue Bought $CHOO already holding

[Jluck @Jluck_2]

@pumamethod Yeah that 54 years celibacy built real silent power

[Jluck @Jluck_2]

@spacetourist0 Forecast of regret is intense way to propose

[Jluck @Jluck_2]

@11Architect11 Ninety percent of orgasms need that clitoral focus first

[ChooChoo @ChooTheRescue]

Left for dead, a rescue nobody wanted, to larger than life making and impact all over the world.

Just. Getting. Started. 🐾

[Jluck @Jluck_2]

@ChooTheRescue $Choo is pure alpha energy

[ChooChoo @ChooTheRescue]

This is EPIC 😍

I am so grateful for all of the love and support.

I can see a real movement in the making…thank you for thinking of me Menalo.

We’d like to airdrop you some $Choo to hold.

🐾

[Jluck @Jluck_2]

@ChooTheRescue This leaf art is insane, holding

[Space Tourist @spacetourist0]

There is a pattern in Elon Musk's relationships that nobody discusses because it implicates a structural reality that is uncomfortable: multiple partners came from within his professional orbit. Shivon worked at Neuralink. Several women he has been linked to were employees, executives, or associates within his companies. The proximity is not coincidental. It is the mechanism.

Elon works 80 to 100 hours per week. His social world is his professional world. The people he sees are the people he works with. The women he meets are the women in his companies. The relationships form not through dating apps or social events but through the organic proximity of shared mission work. The man who never leaves the factory falls for people in the factory.

The dynamic creates an inherent power asymmetry that most corporate governance structures are designed to prevent. The person he is drawn to depends on him for their career. The admiration she may feel is genuine. The power differential is also genuine. The two coexist. The consent is real. The imbalance is also real. Both can be true simultaneously.

The women in his orbit describe a specific phenomenon: the attention of the most powerful man in the room focuses on you and the experience is unlike anything you've prepared for. The focus is total. The intellect is staggering. The resources are infinite. The combination is intoxicating. The transition from "valued employee" to "object of focus" happens gradually, then suddenly. By the time the personal boundary is crossed, the professional relationship has already been altered beyond repair.

The pattern produces children. Shivon had 4 children with the man who runs the company she worked at. The personal and professional became inseparable. The exit from the relationship is also an exit from the professional orbit that defined her career. The cost of leaving the partner includes the cost of leaving the ecosystem.

This is the proximity trap: the man who never leaves work can only meet partners at work. The partners he meets at work are structurally dependent on him. The structural dependency complicates every aspect of the relationship from formation to dissolution. The trap is not set intentionally. It is a byproduct of a life that has no space outside the companies.

The man who has no personal life outside the mission can only build personal relationships inside the mission. The mission then defines, constrains, and ultimately absorbs those relationships. The partners are not trapped by the man. They are trapped by the structure. And the structure was built by the man.

[Jluck @Jluck_2]

@spacetourist0 Power dynamics matter, especially when someone's career depends on you

[The Hair King @jamesbondwisdom]

using commercial shampoo daily to keep your hair healthy sounds like basic hygiene until you read that sodium lauryl sulfate (SLS), the primary foaming agent in 90% of commercial shampoos, strips the entire lipid barrier from your scalp, forces your sebaceous glands to overproduce oil in compensation, and creates the greasy hair cycle that makes you believe you need to shampoo daily. then it sounds like the shampoo industry engineered a chemical dependency where the product creates the condition it claims to treat

the cycle works like this: SLS strips ALL oil from the scalp. the scalp, which needs the lipid layer for protection and moisture retention, detects the total removal and responds by ramping up sebum production. the overproduction makes the hair greasy within 12 to 24 hours. the greasiness triggers the need to shampoo again. the shampoo strips the oil again. the cycle repeats. the consumer believes they have "oily hair." they don't. they have a scalp that is overproducing sebum in response to the daily chemical stripping that the shampoo performs

the mechanism: SLS (sodium lauryl sulfate) and SLES (sodium laureth sulfate) are surfactants designed to dissolve grease. they were developed for industrial degreasing. the same chemistry that removes engine grease from a mechanic's hands removes the protective lipid layer from your scalp. the scalp's lipid layer maintains moisture, protects against UV damage, creates an antimicrobial barrier against fungal and bacterial colonization, and cushions the follicle opening. daily SLS removal of this layer is the equivalent of daily sunburn without the redness. invisible damage. daily accumulation

• the global shampoo market generates $87 billion annually. the market depends on daily or every other day shampooing. if consumers shampooed 2 to 3 times per week (which is dermatologically sufficient), the market would shrink by 40 to 60%. the industry's revenue model requires you to believe daily washing is necessary
• SLS was originally developed as an industrial surfactant for cleaning floors and degreasing engines. it was introduced into personal care products because it is cheap ($0.50 per kilogram), creates satisfying foam, and is extremely effective at removing oil. too effective for the scalp
• the foam that makes shampoo "feel like it's working" is the SLS. the foam has no cleaning function. it is a sensory experience that the consumer has been conditioned to associate with cleanliness. sulfate free shampoos produce less foam. they clean just as effectively. the consumer feels like they don't work because the foam is absent
• when people switch to sulfate free shampoo or reduce washing frequency, the first 2 to 3 weeks involve a "transition period" where the scalp continues overproducing oil (the production rate hasn't reset yet). most people quit during this period and conclude that their hair "needs" daily washing. the dependency is real. the withdrawal is real. the reset takes time
• the conditioner industry ($20 billion) exists primarily to repair the damage that the shampoo industry ($87 billion) creates. SLS strips the cuticle. conditioner smooths it back down. the two products are sold as a "system" when one exists solely because the other causes damage. remove the damaging shampoo. the repair conditioner becomes unnecessary
• indigenous and historical populations that never used surfactant shampoo (washing with water only, clay, or saponin based cleansers like shikakai) show healthier scalps, stronger hair, and lower rates of seborrheic conditions in dermatological surveys

the shampoo industry did not discover a hygiene need and fill it. the industry created a chemical dependency and marketed it as hygiene. the SLS strips the oil. the oil overproduction creates the perceived need to strip again. the cycle generates $87 billion. and the consumer who washes daily because their hair "gets greasy by noon" doesn't realize that the greasiness is the scalp's response to the stripping. not the condition the stripping treats

switch to a sulfate free shampoo or a low surfactant cleanser. wash 2 to 3 times per week instead of daily. the first 2 to 3 weeks will be greasy (the sebaceous glands are still overproducing). by week 3 to 4, sebum production normalizes to match the reduced stripping frequency. the hair stays clean longer. the scalp is healthier. the follicle openings are unobstructed. the $87 billion industry needs you to never discover this

the product you use to clean your hair is the product that makes your hair need cleaning. the chemical that creates the foam creates the stripping. the stripping creates the overproduction. the overproduction creates the next purchase. $87 billion per year. from a chemical cycle that a $12 bottle of sulfate free shampoo breaks in 3 weeks. the industry's most profitable feature is the grease it manufactures inside your own scalp.

[Jluck @Jluck_2]

@jamesbondwisdom Sulfates can irritate some scalps, but the claims seem exaggerated

[The Biohacking Immortal @1Immortals1]

taking a blue dye used in aquariums and laboratory staining to enhance mitochondrial function and cognitive performance sounds like the supplement industry has officially reached peak absurdity until you read that methylene blue was the first fully synthetic drug in medicine (1876), that it is on the WHO's List of Essential Medicines, and that it directly donates and accepts electrons in the mitochondrial electron transport chain at complexes I and III, functioning as an alternative electron carrier that bypasses dysfunctional components and increases ATP production even in damaged mitochondria. then it sounds like a $12 bottle of blue liquid restarting the engines that your aging cells can no longer run efficiently

methylene blue was synthesized in 1876. it was the first synthetic compound used therapeutically in medicine. it has been used to treat malaria, methemoglobinemia, cyanide poisoning, and urinary tract infections. it is on the WHO List of Essential Medicines. the compound has 150 years of human safety data. this is not a new supplement. it is one of the oldest drugs in modern medicine being repurposed for its mitochondrial mechanism

the mechanism: methylene blue is a redox agent that can accept electrons at complex I and donate them at complex III of the mitochondrial electron transport chain. in a healthy mitochondrion, electrons flow through complexes I → III → IV to produce ATP. in an aging or damaged mitochondrion, complex I and III dysfunction slows this flow, reducing ATP output. methylene blue acts as a bypass: it carries electrons past the damaged components and delivers them to the next functional step. the result is increased ATP production from mitochondria that were previously running below capacity. that's it. a bypass for broken engines

- directly increases ATP production by acting as an alternative electron carrier in the mitochondrial electron transport chain. the mechanism is unique among all supplements. nothing else does this
- on the WHO List of Essential Medicines. 150 years of human use. the safety profile is among the most well documented of any compound in pharmacology
- improved memory retention and recall in animal studies at low doses (0.5 to 4mg/kg). the cognitive enhancement is attributed to increased ATP availability in hippocampal neurons
- neuroprotective against Alzheimer's, Parkinson's, and traumatic brain injury in preclinical models. the protection is mitochondrial: more ATP and less oxidative damage in vulnerable neuronal populations
- at low doses (0.5 to 2mg), it acts as an antioxidant by cycling between its oxidized (blue) and reduced (clear) forms, neutralizing reactive oxygen species. at higher doses it becomes a pro oxidant. the dose determines the effect. low is protective. high is damaging
- turns urine blue. this is not a side effect. it is visual confirmation that the compound is being absorbed and excreted. the blue urine is the cheapest bioavailability test in supplementation

pharmaceutical nootropics and mitochondrial support drugs are in development at costs projected at $200+ per month. methylene blue provides direct mitochondrial electron transport support at $12 for a supply lasting 2 to 3 months. the compound that pharmaceutical companies are trying to replicate with patented molecules has been available since 1876

take 0.5 to 2mg per day of USP grade methylene blue (pharmaceutical grade, not aquarium grade which contains impurities). dissolve in water. the liquid turns blue. your tongue turns blue. your urine turns blue. start at 0.5mg and increase gradually. take in the morning (it is mildly stimulating). do NOT take with SSRIs (serotonin syndrome risk at higher doses). troscriptions and blue cannatine make pre dosed sublingual products. $12 to $25 for a 2 to 3 month supply

the first synthetic drug in medicine (1876), on the WHO's List of Essential Medicines, with 150 years of safety data, directly bypasses the broken components of aging mitochondria to produce more energy per cell. $0.13 per day. turns everything blue. and the mitochondrial dysfunction that your doctor calls "aging" has a bypass available for the price of a blue tongue and $12.

[Jluck @Jluck_2]

@1Immortals1 That SSRI interaction alone makes self-experimenting with methylene blue risky

[ChooChoo @ChooTheRescue]

Loveeee 😍

Grateful for your support fren, means the world to me.

My dad is gonna airdrop you some $choo.

Please dm me 🤝

[Jluck @Jluck_2]

@ChooTheRescue Love the IRL grind, true degen energy

[cape @capexbt]

Long your longs gentlemen.